• 猪头巷成网红 不少人去合影留念 2019-10-15
  • 新疆额敏县:“社区影院”助推文化惠民 2019-10-15
  • 人民性是马克思主义最鲜明的品格 2019-10-11
  • 这篇文章写得非常好,现在的人大多都是根据一些简单的事实来判断事情的对错,“一个很漂亮的开奥迪的女人”为了十八块钱与保安对峙 2019-10-09
  • 网购陷阱多 女子花3000元买5套化妆品只有2套是真的 2019-10-04
  • 倒着走能治腰颈椎痛?假的! 2019-10-04
  • 娱乐 —频道 春城壹网 七彩云南 一网天下 2019-09-26
  • 庭审直播成常态 告别选择性公开 2019-09-23
  • 重庆市南川区:社区“法律诊所”推进普法依法治理 2019-09-23
  • 习近平主持上海合作组织青岛峰会小范围会谈 2019-09-16
  • 济南时报总编辑赵治国祝贺人民日报创刊70周年 2019-09-10
  • 世界杯老司机速成手册:球场之上,谁的眼泪在飞 2019-09-05
  • 女性之声——全国妇联 2019-09-04
  • 2018孩迷全国乐队大赛&孩迷音乐夏令营报名启动孩迷 夏令营 2019-09-03
  • 打造一流服务商 丽江旅游诠释“品、特、优”发展理念 2019-08-31
  • 天天酷跑超神宠
    简体|繁體
    Company News
    Year:
    2019
    15/05/2019Essex Bio-Technology Included by MSCI as A Constituent of The MSCI China Small Cap Index
    29/04/2019Essex Bio-Technology Announces Upcoming Joint Presentation with Mitotech and Ora at ARVO 2019 Annual Meeting
    12/03/2019FY18 Turnover & Net Profit grew 30.8% and 38.1% to HK$1,176.5 million & HK$ 231.1 million, respectively
    11/01/2019The cellular growth factor project of Essex Bio-Technology Limited was honored with the second prize of National Scientific and Technology Progress Award
    2018
    30/10/2018Essex Bio-technology Entered into Convertible Notes Purchase Agreement and License Agreement with DB Therapeutics—Its Radioactive Bandages For The Treatment Of Non-Melanoma Skin Cancer (NMSC)
    29/10/2018Essex Bio-Technology Announces First Patient First Visit in U.S. FDA Phase 3 Clinical Trial of SkQ1 Occurred on 27 October 2018
    22/08/2018Preservative-free Single-dose Sodium Hyaluronate Eye Drops Obtained Approval from SDA for Commercilisation in China
    10/08/2018Group Turnover and Profit in the First Half of 2018 Increased 28.3%
    24/07/2018Essex Bio-Technology Investing in Chengdu Shanggong Medical Technology Co.,Ltd
    18/07/2018Essex Bio-Technology Enters into Global Co-Development Agreement with Mitotech
    13/04/2018Zhuhai Essex Bio-Pharmaceutical Obtained a GMP Cerficate for Preservative-Free Single-Dose Tobramycin Eye Drops
    10/04/2018Essex Bio-Technology appoints Dr.Xue Qi as Chief Scientific Officer for its R&D centre in USA
    19/03/2018Group Profit Recorded Growth of 22.8% in 2017
    06/03/2018Change of Company Logo Represents a Transformation for Essex Bio-Technology
    26/02/2018Essex Bio-Technology announces investment in MeiraGTx, a biotech company developing novel gene therapy treatments
    2017
    22/05/2017AC Immune and Essex Bio-Technology announce research collaboration for neurodegenerative diseases and neuroinflammation
    2016
    07/04/2016HUMACYTE,INC.,one of the investments of the group,made research and development progress in Q1 2016
    21/03/2016Group turnover and profit recorded growth of 26.2% to HK$654M & 39.4% to HK$104.9 respectively
    2015
    28/08/2015EssexBio and Tasly to co-develop recombinant protein drugs under Strategic Co-Operation Framework Agreement
    18/03/2015Group turnover and profit recorded growth of 49.3% & 37.1% respectively
    2014
    07/08/2014Growth of 40.1% & 13.8% in turnover and profit respectively
    15/05/2014Announcement obtaining of a health food certificate by a wholly-owned subsidiary
    28/04/2014Zhuhai Essex Bio-Pharmaceutical Company Limited Bestowed the Award of Outstanding Enterprise of 2013(Guangdong Province)
    17/02/2014Announcement import and service agreement with Pfizer international trading (ShangHai) LTD.
    2013
    31/12/2013Obtaining of a certificate of good manufacturing practices for human drugs by a wholly-owed subsidiary
    2011
    03/08/2011Group recorded first half growth of 53.6% & 34.4% in turnover and profit respectively
    23/06/2011Essex Bio-Technology Limited successfully transferred the listing from the gem board to the main board (stock code on main board: 1061) (stock code on gem: 8151)
    12/05/2011Group pharmaceutical business recorded first quarter growth of 74.3% & 44.0% in turnover and profit respectively
    28/03/2011Group pharmaceutical business recorded growth of 25.4% & 58.7% in turnover and profit respectively
    2010
    04/11/2010Group pharmaceutical business recorded growth of 22.4% & 45.1% in turnover and profit respectively
    11/08/2010Group pharmaceutical business recorded growth of 22.6% & 38.3% in turnover and profit respectively
    25/03/2010Group pharmaceutical business recorded moderate growth of 25.6% in revenue
  • 猪头巷成网红 不少人去合影留念 2019-10-15
  • 新疆额敏县:“社区影院”助推文化惠民 2019-10-15
  • 人民性是马克思主义最鲜明的品格 2019-10-11
  • 这篇文章写得非常好,现在的人大多都是根据一些简单的事实来判断事情的对错,“一个很漂亮的开奥迪的女人”为了十八块钱与保安对峙 2019-10-09
  • 网购陷阱多 女子花3000元买5套化妆品只有2套是真的 2019-10-04
  • 倒着走能治腰颈椎痛?假的! 2019-10-04
  • 娱乐 —频道 春城壹网 七彩云南 一网天下 2019-09-26
  • 庭审直播成常态 告别选择性公开 2019-09-23
  • 重庆市南川区:社区“法律诊所”推进普法依法治理 2019-09-23
  • 习近平主持上海合作组织青岛峰会小范围会谈 2019-09-16
  • 济南时报总编辑赵治国祝贺人民日报创刊70周年 2019-09-10
  • 世界杯老司机速成手册:球场之上,谁的眼泪在飞 2019-09-05
  • 女性之声——全国妇联 2019-09-04
  • 2018孩迷全国乐队大赛&孩迷音乐夏令营报名启动孩迷 夏令营 2019-09-03
  • 打造一流服务商 丽江旅游诠释“品、特、优”发展理念 2019-08-31
  • 欢乐炸金花 单双大小投注技巧大全 破解北京赛车pk10软件 重庆时时彩软件计划 九天娱乐官网 时时彩计划 江西时时中奖事件 澳客 老时时开奖号码 骰宝押大小规律图 三公大吃小玩法 江苏快3计划软件助手 至尊牌九安卓版下载 百家了乐八大技巧 足球彩票比分直播 北京pk赛车能不能赢钱